Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation

NCT03851211 is registered in ClinicalTrials.gov with The Leeds Teaching Hospitals NHS Trust as lead sponsor.

NCT NCT03851211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03851211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation
Lead sponsor
The Leeds Teaching Hospitals NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
February 21, 2019
Completion date
October 30, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer